Nuvectis Pharma Inc
NVCT7.180USD
+0.380+5.59%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
169.70MMarket Cap
LossP/E TTM
Nuvectis Pharma Inc
7.180
+0.380+5.59%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q2
Total equity
Cash, cash equivalents and short-term investments
53.43%29.86M
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
-6.69%22.06M
81.26%24.60M
-7.34%15.47M
248.19%19.99M
--23.64M
88.13%13.57M
--16.69M
--5.74M
--7.21M
- Cash and cash equivalents
53.43%29.86M
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
-6.69%22.06M
81.26%24.60M
-7.34%15.47M
248.19%19.99M
--23.64M
88.13%13.57M
--16.69M
--5.74M
--7.21M
Other current assets
13.60%284.00K
25.42%74.00K
-32.02%138.00K
-46.63%182.00K
-66.22%250.00K
-85.68%59.00K
-83.44%203.00K
-48.80%341.00K
-20.00%740.00K
352.75%412.00K
--1.23M
--666.00K
--925.00K
--91.00K
----
Total current assets
52.93%30.15M
-3.01%18.61M
-22.26%17.31M
-26.63%18.30M
21.63%19.71M
-5.98%19.18M
-10.47%22.26M
75.17%24.94M
-8.00%16.21M
249.82%20.41M
--24.87M
97.37%14.24M
--17.62M
--5.83M
--7.21M
Non-current assets
Other non-current assets
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--0.00
--0.00
--824.00K
----
Total non-current assets
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--0.00
--0.00
--824.00K
----
Total assets
52.93%30.15M
-3.01%18.61M
-22.26%17.31M
-26.63%18.30M
21.63%19.71M
-5.98%19.18M
-10.47%22.26M
75.17%24.94M
-8.00%16.21M
206.52%20.41M
--24.87M
97.37%14.24M
--17.62M
--6.66M
--7.21M
Liabilities
Current liabilities
-Other payables
--300.00K
----
----
----
----
----
-100.00%0.00
17.01%399.00K
-100.00%0.00
-45.39%450.00K
--640.00K
--341.00K
--921.00K
--824.00K
----
Accrued expenses
50.06%5.90M
51.82%6.40M
94.58%4.05M
63.02%3.92M
113.98%3.93M
49.08%4.21M
30.17%2.08M
149.95%2.41M
132.95%1.84M
426.26%2.83M
--1.60M
--963.00K
--789.00K
--537.00K
----
Other current liabilities
--300.00K
----
----
----
----
----
-100.00%0.00
17.01%399.00K
-100.00%0.00
-45.39%450.00K
--640.00K
--341.00K
--921.00K
--824.00K
----
Total current liabilities
61.52%9.19M
27.35%8.89M
13.27%6.32M
25.19%5.77M
44.69%5.69M
12.90%6.98M
24.13%5.58M
68.33%4.61M
28.60%3.93M
155.73%6.19M
--4.49M
603.86%2.74M
--3.06M
--2.42M
--389.00K
Non-current liabilities
Long-term debt and lease liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Other non-current liabilities
--0.00
----
----
----
----
----
----
----
----
----
----
----
---127.00
---2.44
----
Total non-current liabilities
----
----
----
----
----
----
----
----
----
----
----
----
---127.00
---2.44
----
Total liabilities
61.52%9.19M
27.35%8.89M
13.27%6.32M
25.19%5.77M
44.69%5.69M
12.90%6.98M
24.13%5.58M
68.33%4.61M
28.61%3.93M
155.73%6.19M
--4.49M
603.86%2.74M
--3.06M
--2.42M
--389.00K
Shareholders' equity
Common equity
37.40%99.53M
24.85%82.96M
21.27%77.99M
21.42%75.37M
49.95%72.44M
43.81%66.45M
40.83%64.31M
100.81%62.07M
58.90%48.31M
2342.08%46.20M
--45.66M
1867.67%30.91M
--30.40M
--1.89M
--1.57M
Retained earnings
-34.51%-78.58M
-35.03%-73.25M
-40.68%-67.00M
-50.55%-62.84M
-62.11%-58.42M
-69.60%-54.24M
-88.32%-47.62M
-115.03%-41.74M
-127.44%-36.03M
-147.95%-31.98M
---25.29M
-225.10%-19.41M
---15.84M
---12.90M
---5.97M
Capital reserves
37.40%99.53M
24.85%82.96M
21.27%77.99M
21.42%75.37M
49.95%72.44M
43.81%66.45M
40.83%64.31M
100.81%62.07M
58.90%48.31M
2342.07%46.20M
--45.66M
1867.66%30.91M
--30.40M
--1.89M
--1.57M
Total equity
49.44%20.95M
-20.39%9.71M
-34.13%10.99M
-38.38%12.53M
14.24%14.02M
-14.19%12.20M
-18.10%16.69M
76.80%20.33M
-15.70%12.27M
235.51%14.22M
--20.37M
68.50%11.50M
--14.56M
--4.24M
--6.83M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
